Details for New Drug Application (NDA): 022220
✉ Email this page to a colleague
The generic ingredient in TRIVARIS is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Sixty-nine suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
Summary for 022220
Tradename: | TRIVARIS |
Applicant: | Allergan |
Ingredient: | triamcinolone acetonide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 022220
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INTRA-ARTICULAR, INTRAMUSCULAR, INTRAVITREAL | Strength | 8MG/0.1ML (8MG/0.1ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jun 16, 2008 | TE: | RLD: | Yes |
Complete Access Available with Subscription